转基因烟草作为生产生物活性和三螺旋复合III型原体的生物反应器
Tairu Wu1, Weisong Pan2,3, Jiahao Pan1
1College of Metallurgy and Environment, Central South University, Changsha 410083, China.
Plants (Basel, Switzerland)
|March 14, 2026
概括
科学家们对烟草植物进行了改造,以产生人体III型原蛋白 (rhCOL3),这是细胞结构的关键蛋白质. 这种植物制造的原蛋白具有功能性,稳定性,并有可能用于再生医学应用.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 植物科学 植物科学
背景情况:
- 原蛋白对于细胞外基质结构和功能至关重要.
- 产生适当的翻译后修改的重组原蛋白是具有挑战性的.
- 第三类原蛋白对皮肤和骨的完整性至关重要.
研究的目的:
- 在转基因烟草植物中开发一种生产复合人体III型原蛋白 (rhCOL3) 的方法.
- 为了确保适当的翻译后修改和植物性原蛋白的三环螺旋形成.
- 评估产生的 rhCOL3.3 的生物活性和稳定性.
主要方法:
- 为表达人类的COL3A1基因和烟草中必要的翻译后修饰酶而构建的载体.
- 使用这些载体转基因改造烟草植物.
- 从转基因谱系中净化和特征化了复合型III原.
主要成果:
- 在烟草植物中成功联合表达了COL3A1基因和四种修饰酶.
- 通过共同表达的酶 (PCP和PNP) 证明了终端的正确裂解.
- 确认了植物衍生rhCOL3的热稳定性和生物活性,该物质形成了三螺旋结构.
结论:
- 在转基因烟草中成功生产了具有三环螺旋结构的功能性,全长,成熟的III型原体.
- 这种植物制造的原蛋白是再生医学的基础材料,特别是用于皮肤和骨的修复.
- 烟草植物可以作为有效的生物反应器,生产复杂的重组人体蛋白质,如原蛋白.
更多相关视频
09:11A Comparative Analysis of Recombinant Protein Expression in Different Biofactories: Bacteria, Insect Cells and Plant Systems
Published on: March 23, 2015
24.6K
08:43Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
8.1K
相关概念视频
Transgenic Plants
9.0K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
9.0K
Transgenic Organisms
34.2K
Overview
34.2K
